104 Results for "

CD73

" in MedChemExpress (MCE) Product Catalog:
Products (104)

104 Results for "CD73" in MCE Product Catalog:

23
23 Publications Verification
Cat. No.: HY-125286
CAS No.: 2105904-82-1
Purity:  99.71%
Target:  

CD73

Research Areas:  

Cancer

AB-680 is a highly potent, reversible and selective inhibitor of CD73 (an ecto-nucleotidase), with a Ki of 4.9 pM for hCD73, displays >10,000-fold selectivity over related ecto-nucleotidases CD39. Anti-tumor activity .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-100747
CAS No.: 1802226-78-3
Purity:  98.08%
Target:  

CD73

Research Areas:  

Cancer

PSB-12379, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase (CD73) inhibitor with Kis of 9.03 nM (rat) and 2.21 nM (human) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-103265
CAS No.: 1021868-83-6
Purity:  99.94%
Synonyms: FPL 67156 trisodium
Target:  

NTPDase

ARL67156 (FPL 67156) trisodium is a selective small molecular inhibitor, targeting to ecto-ATPase, CD39, and CD73. ARL67156 trisodium is also a competitive inhibitor of NTPDase1 (CD39), NTPDase3 and NPP1, with Kis of 11, 18 and 12?μM, respectively. ARL67156 trisodium can be used in the research of calcific aortic valve disease, asthma .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-103265D
Synonyms: FPL 67156 triethylamine
Target:  

NTPDase

ARL67156 (FPL 67156) triethylamine is a selective small is a selective samll molecular inhibitor, targeting to ecto-ATPase, CD39, and CD73. ARL67156 triethylamine is also a competitive inhibitor of NTPDase1 (CD39), NTPDase3 and NPP1, with Kis of 11, 18 and 12 μM, respectively. ARL67156 triethylamine can be used in the research of disease like calcific aortic valve disease, asthma .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99039
CAS No.: 1803176-05-7
Synonyms: MEDI9447

Target:  

CD73

Research Areas:  

Cancer

Oleclumab (MEDI9447) is a human IgG1λ monoclonal antibody targeting CD73 and inhibits the exonuclease activity of the extracellular enzyme CD73. Oleclumab can adjust the composition of bone marrow and lymphoid infiltrating leukocyte populations in the tumor microenvironment and has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-137246
CAS No.: 2375815-63-5
Purity:  99.89%
Target:  

CD73

Research Areas:  

Cancer

CD73-IN-3 is a potent CD73 inhibitor (IC50=7.3 nM in Calu6 human cell assay). CD73-IN-3, example 2 extracted from patent WO2019168744 A1, has the potential for cancer research .
loading...
    loading...
Cat. No.: HY-112502
CAS No.: 3768-14-7
Purity:  ≥99.0%
Synonyms: Adenosine 5'-(α,β-methylene)diphosphate
Target:  

CD73

Research Areas:  

Cancer

MethADP is a specific CD73 inhibitor.
loading...
    loading...
Cat. No.: HY-P99181
CAS No.: 2451856-97-4
Synonyms: CPI-006

Target:  

CD73

Mupadolimab (CPI-006) is an IgG1κ humanized FcγR binding-deficient anti-CD73 monoclonal antibody (mAb) that activates CD73 POS B cells .
loading...
    loading...
Cat. No.: HY-145334
CAS No.: 2412019-99-7
Purity:  98.14%
Target:  

CD73

Research Areas:  

Cancer

CD73-IN-5 is a potent and selective non-nucleotide small molecule inhibitor of CD73 (IC50 = 19 nM).
loading...
    loading...
Cat. No.: HY-103695
CAS No.: 2132396-40-6
Purity:  99.46%
Target:  

CD73

Research Areas:  

Cancer

CD73-IN-1 is an inhibitor of CD73 which can be used in the treatment of cancer extracted from patent WO 2017153952 A1, example 80.
loading...
    loading...
Cat. No.: HY-P99169
CAS No.: 2378407-27-1
Synonyms: TJ004309

Target:  

CD73

Research Areas:  

Cancer

Uliledlimab is a potent against CD73 humanizedized monoclonal antibody. Uliledlimab inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab can be used in research of cancer .
loading...
    loading...
Cat. No.: HY-P990263

Target:  

CD73

Anti-Mouse CD73 Antibody (TY/23) is a rat-derived IgG2a κ type antibody inhibitor, targeting to mouse CD73. Anti-Mouse CD73 Antibody (TY/23) can neutralize CD73. Anti-Mouse CD73 Antibody (TY/23) can be used for the researches of cancer, infection and immunology, such as B16F10 tumor and murine cytomegalovirus infection .
loading...
    loading...
Cat. No.: HY-P3260
CAS No.: 9027-73-0
Synonyms: CD73; 5′-NT
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease Cancer

5′-Nucleotidase, Microorganism (CD73) is an intrinsic membrane glycoprotein present as an ectoenzyme. 5′-Nucleotidase catalyzes hydrolysis of 5-nucleotides to their corresponding nucleosides .
loading...
    loading...
Cat. No.: HY-131967
CAS No.: 2216764-29-1
Purity:  99.21%
Target:  

CD73

Research Areas:  

Inflammation/Immunology Cancer

CD73-IN-4 is a potent and selective methylenephosphonic acid CD73 inhibitor, with an IC50 of 2.6 nM for human CD73. CD73-IN-4 is potential for the research of cancer immunology .
loading...
    loading...
Cat. No.: HY-160696
CAS No.: 2641306-62-7
Target:  

CD73

Research Areas:  

Cancer

ORIC-533 is an orally active, highly selective, AMP-competitive CD73 inhibitor that potently blocks adenosine production with sub-nanomolar affinity (Ka=0.03 nM). In multiple myeloma, ORIC-533 restores and enhances the cytotoxicity of the immune system against tumor cells through multiple immunological mechanisms, including reversing the immunosuppressive microenvironment, inducing immunogenic cell death, and activating dendritic cells, T cells and NK cells, with no direct toxicity to normal cells. The combination of ORIC-533 with Daratumumab (HY-P9915) synergistically enhances anti-tumor efficacy, significantly increases intratumoral CD8 + T cell infiltration and inhibits tumor growth in vivo .
loading...
    loading...
Cat. No.: HY-173447
CAS No.: 344402-39-7
Target:  

NTPDase CD73

Research Areas:  

Cancer

8-BuS-AMP is a NTPDase1 inhibitor and a CD73/CD39 inhibitor, with an IC50 of 35 μM and a Ki value of 0.292 μM against human NTPDase1; its Ki values against human CD73 and CD39 are 1.19 μM and 0.847 μM, respectively. 8-BuS-AMP binds to the substrate-binding pockets of NTPDase1 and CD73 to effectively block the conversion of ATP and AMP to adenosine, thereby enhancing the activation and proliferation of human peripheral T lymphocytes. 8-BuS-AMP possesses excellent enzymatic hydrolysis resistance and metabolic stability, resists hydrolysis by multiple NTPDase subtypes, and shows no activity against P2Y1 and P2Y12 receptors. 8-BuS-AMP can be used in purinergic signaling pathway and cancer-related studies .
loading...
    loading...
Cat. No.: HY-103265B
Purity:  99.94%
Synonyms: FPL 67156 trisodium hydrate
Target:  

NTPDase

ARL67156 (FPL 67156) trisodium hydrate is a selective small is a selective samll molecular inhibitor, targeting to ecto-ATPase, CD39, and CD73. ARL67156 trisodium hydrate is also a competitive inhibitor of NTPDase1 (CD39), NTPDase3 and NPP1, with Kis of 11, 18 and 12 μM, respectively. ARL67156 trisodium hydrate can be used in the research of disease like calcific aortic valve disease, asthma .
loading...
    loading...
Cat. No.: HY-P99865
CAS No.: 2550560-20-6
Synonyms: AK-119

Target:  

CD73

Research Areas:  

Others

Dresbuxelimab (AK-119) is an IgG-κ monoclonal antibody targeting CD73. The expression system is usually CHO (Chinese Hamster Ovary) cells .
loading...
    loading...
Cat. No.: HY-P99841
CAS No.: 2419918-89-9
Synonyms: AGEN-1423; GS-1423

Target:  

CD73 TGF-β Receptor

Research Areas:  

Inflammation/Immunology Cancer

Dalutrafusp alfa (AGEN-1423; GS-1423) is a specific bifunctional antibody against CD73 and TGF-β, which is involved in the immunosuppressive pathway .
loading...
    loading...
Cat. No.: HY-131435
CAS No.: 2452209-05-9
Target:  

CD73

Research Areas:  

Cancer

CD73-IN-2 is a potent CD73 inhibitor extracted from WO2020151707A1, example 1, has an IC50 of 0.09 nM .
loading...
    loading...